These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29478350)

  • 1. Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases.
    Bonucci M; Pastore C; Ferrera V; Fiorentini C; Fabbri A
    Integr Cancer Ther; 2018 Sep; 17(3):994-999. PubMed ID: 29478350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future.
    Pokorny AMJ; Chin VT; Nagrial AM; Yip D; Chantrill LA
    Intern Med J; 2018 Jun; 48(6):637-644. PubMed ID: 29898269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of metastatic pancreatic adenocarcinoma with prolonged survival after combination of neoadjuvant FOLFIRINOX therapy and synchronous distal pancreatectomy and hepatectomy.
    Neofytou K; Giakoustidis A; Smyth EC; Cunningham D; Mudan S
    J Surg Oncol; 2015 May; 111(6):768-70. PubMed ID: 25556724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.
    Barenboim A; Lahat G; Geva R; Nachmany I; Nakache R; Goykhman Y; Brazowski E; Rosen G; Isakov O; Wolf I; Klausner JM; Lubezky N
    Eur J Surg Oncol; 2018 Oct; 44(10):1619-1623. PubMed ID: 30146251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term tumor-free survival in a metastatic pancreatic carcinoma patient with FOLFIRINOX/Mitomycin, high-dose, fever inducing Viscum album extracts and subsequent R0 resection: A case report.
    Werthmann PG; Inter P; Welsch T; Sturm AK; Grützmann R; Debus M; Sterner MG; Kienle GS
    Medicine (Baltimore); 2018 Dec; 97(49):e13243. PubMed ID: 30544385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical recommendations for the management of adenocarcinoma of the pancreas.
    Sporn JR
    Drugs; 1999 Jan; 57(1):69-79. PubMed ID: 9951952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resectable pancreatic adenocarcinomas: will neoadjuvant FOLFIRINOX replace upfront surgery in the standard of care?
    Antonios A; Gharios J; Tohme C
    Future Oncol; 2017 May; 13(11):951-953. PubMed ID: 28481149
    [No Abstract]   [Full Text] [Related]  

  • 8. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
    Schlick K; Magnes T; Ratzinger L; Jaud B; Weiss L; Melchardt T; Greil R; Egle A
    PLoS One; 2018; 13(11):e0206688. PubMed ID: 30412592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intra-arterial infusion chemotherapy in combination with microwave hyperthermia for cancer of head of pancreas and liver metastasis--a case of 16 years survival].
    Miura T; Endo Y; Matumoto Y; Ikeda H
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1794-800. PubMed ID: 11086415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring Balance for People with Cancer Through Integrative Oncology.
    Fulop JA; Grimone A; Victorson D
    Prim Care; 2017 Jun; 44(2):323-335. PubMed ID: 28501232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery combined with intraoperative chemo-hyperthermia and postoperative radiotherapy in the management of advanced pancreatic adenocarcinoma: feasibility aspects and efficacy.
    Kouloulias VE; Nikita KS; Kouvaris JR; Uzunoglu NK; Golematis VC; Papavasiliou CG; Vlahos LJ
    J Hepatobiliary Pancreat Surg; 2001; 8(6):564-70. PubMed ID: 11956909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study.
    Safran H; Charpentier KP; Perez K; Mantripragada K; Miner T; DiPetrillo T; Kuritzky B; Apor E; Bishop K; Luppe D; Mitchell K; Rosati K
    Am J Clin Oncol; 2016 Dec; 39(6):619-622. PubMed ID: 26523444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study.
    Hildebrandt B; Wust P; Dräger J; Lüdemann L; Sreenivasa G; Tullius SG; Amthauer H; Neuhaus P; Felix R; Riess H
    Int J Hyperthermia; 2004 Jun; 20(4):359-69. PubMed ID: 15204518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreas.
    Zimmermann FB; Jeremic B; Lersch C; Geinitz H; Hennig M; Molls M
    Hepatogastroenterology; 2005; 52(61):246-50. PubMed ID: 15783041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
    Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
    Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy.
    Erstad DJ; Sojoodi M; Taylor MS; Ghoshal S; Razavi AA; Graham-O'Regan KA; Bardeesy N; Ferrone CR; Lanuti M; Caravan P; Tanabe KK; Fuchs BC
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29903803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer.
    Lischalk JW; Burke A; Chew J; Elledge C; Gurka M; Marshall J; Pishvaian M; Collins S; Unger K
    J Gastrointest Cancer; 2018 Jun; 49(2):116-123. PubMed ID: 28044263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative hyperthermia in conjunction with multi-schedule chemotherapy (pre-, intra- and post-operative), by-pass surgery, and post-operative radiotherapy for the management of unresectable pancreatic adenocarcinoma.
    Kouloulias VE; Kouvaris JR; Nikita KS; Golematis BC; Uzunoglu NK; Mystakidou K; Papavasiliou C; Vlahos L
    Int J Hyperthermia; 2002; 18(3):233-52. PubMed ID: 12028639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis.
    Baldini C; Escande A; Bouché O; El Hajbi F; Volet J; Bourgeois V; Renaut Vantroys T; Ploquin A; Desauw C; Hebbar M
    Pancreatology; 2017; 17(1):146-149. PubMed ID: 28040425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.